Shlomchik and Pear [10] reported that the GVL effect is not reduced in Fas-deficient mice, which implies that the TRAIL/death receptor interaction might influence the elimination of immune-mediated CML malignant cloning. Here, TNFSF10 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.